The chemical synthesis peptide drugs market size was valued at USD 2.57 billion in 2024 and is predicted to hit around USD ...

SCOTTSDALE, AZ / ACCESS Newswire / December 14, 2025 / Infinity Chem, operating through its website at today announced the ...

Gene editing can repair mutations that prematurely halt protein synthesis, resulting in incomplete peptides that cause various diseases. However, other approaches achieve the same effect without ...

The City of Huntsville has taken another step toward bringing pharmaceutical giant Eli Lilly’s $6 billion facility to the ...

The year 2025 was a year of beauty innovation, bold experimentation, and self-expression, but it was defined less by ...

Biocon launches Liraglutide injection (Diavorin & Vobexoryn) for diabetes and weight management in the Netherlands with ...

Biocon launches its glucagon-like peptide-1, liraglutide in Netherlands: Our Bureau, Bengaluru Monday, December 15, 2025, 13:30 Hrs [IST] Biocon has launch of its GLP-1 peptide, l ...

Huntsville, Alabama, has always been known as the “Rocket City,” but the story here is starting to shift. The city is now ...

Biocon Ltd on Monday said it has launched its diabetes and chronic, Liraglutide, in the Netherlands through its distribution partner, Pharmamedic BV.   The drug-device combination will be marketed in ...

Bengaluru: Biocon Limited, a global biopharmaceutical company, has announced the launch of its GLP-1 peptide, Liraglutide, ...

Killer” just got popped. Two-time Professional Fighters League (PFL) Featherweight champion Movlid Khaybulaev has been suspended for one year after testing positive for a banned substance, according ...